Jefferies raises Praxis Medicines stock target to $128 on trial success By Investing.com
On Tuesday, Jefferies updated its assessment of Praxis Precision Medicines Inc. (NASDAQ:PRAX), elevating the stock price target to $128 from ...
On Tuesday, Jefferies updated its assessment of Praxis Precision Medicines Inc. (NASDAQ:PRAX), elevating the stock price target to $128 from ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.